TREMFYA® is a prescription medicine that may cause serious side effects, including serious allergic reactions and infections. TREMFYA® affects your immune system. It may increase your risk of infections and lower your ability to fight them. Please read the Important Safety Information on the next page and the Medication Guide, After finishing your starter doses, you will receive TREMFYA ® subcutaneously (under the skin) as:. A 200 mg dose every 4 weeks starting at week 12; OR; A 100 mg dose every 8 weeks starting at week 16; Your doctor will prescribe the right dose for you. Use TREMFYA ® exactly as prescribed., Results with SC initial and maintenance dosing: Clinical remission at week 12: 56% (400 mg). Endoscopic response at week 12: 34% (400 mg). *40% (200 mg) and 31% (100 mg) achieved endoscopic remission at one year. Based on areas visualized on colonoscopy, which may not represent the deeper bowel layer or entire GI tract., In clinical trials, of patients receiving TREMFYA ®: 23% (200 mg IV) were in clinical remission at 12 weeks. 50% (200 mg SC) and 45% (100 mg SC) were in clinical remission at one year. *34% (200 mg SC) and 35% (100 mg SC) achieved endoscopic remission at one year. Visually assessed areas may not represent remission of the entire colon lining., The support and resources provided by TREMFYA withMe are not intended to give medical advice, replace a treatment plan you receive from your doctor or nurse, or serve as a reason for you to start or stay on treatment. Actor portrayal. TREMFYA withMe Nurse Guides do not provide medical advice. Please ask your doctor any questions you might have , The support and resources provided by TREMFYA withMe are not intended to give medical advice, replace a treatment plan you receive from your doctor or nurse, or serve as a reason for you to start or stay on treatment. Actor portrayal. TREMFYA withMe Nurse Guides do not provide medical advice. Please ask your doctor any questions you might have .